Pharma’s New Patient Access Website: A Signal for Insurers?
PhRMA introduces an online platform connecting patients with discounted pharmaceuticals as the U.S. government pressures drug companies to reform pricing and distribution.
Senator Welch Urges Bipartisan Action to Protect ACA Tax Credits and Avoid Shutdown
Senator Peter Welch calls for bipartisan cooperation to extend ACA tax credits and prevent a government shutdown that threatens affordable healthcare for millions.
Medicare Telehealth Flexibilities Face Expiration Amid Congressional Funding Deadlock
Key Medicare telehealth flexibilities are set to expire September 30, 2025, amid stalled Congressional funding talks, risking rollback of virtual care policies and reimbursement.
Solange De Lahongrais Named President of Puerto Rico Medicaid and Medicare Advantage Association
Solange De Lahongrais appointed as president of Puerto Rico Medicaid and Medicare Advantage Products Association, focusing on federal funding parity and program sustainability ahead of Medicaid funding expiration in 2027.
Georgia Secures Federal Extension for Medicaid Work Requirement Program
Georgia obtains a one-year federal extension for its Medicaid Pathways to Coverage work requirement program, with eased reporting rules and expanded eligibility, amid administrative cost scrutiny.
AI-Assisted Prior Authorization Pilot Launches in Washington Medicare
The federal government starts a 6-year AI-assisted prior authorization pilot in Washington and five other states to improve Medicare coverage decisions for costly procedures.
Impact of MFN Drug Pricing Policy on Medicare Part D Deadline Approaches
The looming deadline for drugmakers to comply with the Most Favored Nation drug pricing policy raises concerns over potential disruptions to Medicare Part D, highlighting regulatory and market risks for U.S. drug pricing and federal entitlement programs.
Medicare Part D Coverage Tightens as GLP-1 Drug Costs and Prior Authorizations Rise
Medicare Part D sees near-universal prior authorization and rising out-of-pocket costs for GLP-1 drugs in 2025, reflecting insurer adjustments to new cost and regulatory pressures.
Trump Administration's H-1B Visa Fee Impact on Healthcare Workforce and Hospital Trends
The Trump administration's $100,000 H-1B visa fee poses challenges for the healthcare workforce, especially in rural areas, amid hospital closures, regulatory penalties, and healthcare market shifts.
Senate Democrats Block GOP Funding Bill, Raising US Government Shutdown Risks
Senate Democrats utilize filibuster to block Republican stopgap funding bill, heightening risk of US government shutdown due to Obamacare subsidy extension dispute and budget negotiations.